Literature DB >> 22711526

Detection of rare and possibly carcinogenic human papillomavirus genotypes as single infections in invasive cervical cancer.

Daan Geraets1, Laia Alemany, Nuria Guimera, Silvia de Sanjose, Maurits de Koning, Anco Molijn, David Jenkins, Xavier Bosch, Wim Quint.   

Abstract

The contribution of carcinogenic human papillomavirus (HPV) types to the burden of cervical cancer has been well established. However, the role and contribution of phylogenetically related HPV genotypes and rare variants remains uncertain. In a recent global study of 8977 HPV-positive invasive cervical carcinomas (ICCs), the genotype remained unidentified in 3.7% by the HPV SPF10 PCR-DEIA-LiPA25 (version 1) algorithm. The 331 ICC specimens with unknown genotype were analysed by a novel sequence methodology, using multiple selected short regions in L1. This demonstrated HPV genotypes that have infrequently or never been detected in ICC, ie HPV26, 30, 61, 67, 68, 69, 73 and 82, and rare variants of HPV16, 18, 26, 30, 34, 39, 56, 67, 68, 69, 82 and 91. These are not identified individually by LiPA25 and only to some extent by other HPV genotyping assays. Most identified genotypes have a close phylogenetic relationship with established carcinogenic HPVs and have been classified as possibly carcinogenic by IARC. Except for HPV85, all genotypes in α-species 5, 6, 7, 9 and 11 were encountered as single infections in ICCs. These species of established and possibly carcinogenic HPV types form an evolutionary clade. We have shown that the possibly carcinogenic types were detected only in squamous cell carcinomas, which were often keratinizing and diagnosed at a relatively higher mean age (55.3 years) than those associated with established carcinogenic types (50.9 years). The individual frequency of the possibly carcinogenic types in ICCs is low, but together they are associated with 2.25% of the 8338 included ICCs with a single HPV type. This fraction is greater than seven of the established carcinogenic types individually. This study provides evidence that possibly carcinogenic HPV types occur as single infections in invasive cervical cancer, strengthening the circumstantial evidence of a carcinogenic role.
Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  HPV26; HPV30; HPV67; HPV73; HPV82; carcinogenic; cervical cancer; high-risk; human papillomavirus; oncogenic

Mesh:

Substances:

Year:  2012        PMID: 22711526     DOI: 10.1002/path.4065

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  17 in total

1.  Genetic variability of human papillomavirus type 66 L1 gene among women presenting for cervical cancer screening in Chile.

Authors:  Monserrat Balanda; Jorge Fernández; Nicolás Vergara; Constanza Campano; Loredana Arata; Héctor San Martín; Eugenio Ramírez
Journal:  Med Microbiol Immunol       Date:  2019-06-04       Impact factor: 3.402

Review 2.  Opportunities and challenges for human papillomavirus vaccination in cancer.

Authors:  Richard B S Roden; Peter L Stern
Journal:  Nat Rev Cancer       Date:  2018-03-02       Impact factor: 60.716

3.  Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide.

Authors:  Laia Alemany; Maëlle Saunier; Isabel Alvarado-Cabrero; Beatriz Quirós; Jorge Salmeron; Hai-Rim Shin; Edyta C Pirog; Núria Guimerà; Gustavo Hernandez-Suarez; Ana Felix; Omar Clavero; Belen Lloveras; Elena Kasamatsu; Marc T Goodman; Brenda Y Hernandez; Jan Laco; Leopoldo Tinoco; Daan T Geraets; Charles F Lynch; Vaclav Mandys; Mario Poljak; Robert Jach; Josep Verge; Christine Clavel; Cathy Ndiaye; JoEllen Klaustermeier; Antonio Cubilla; Xavier Castellsagué; Ignacio G Bravo; Michael Pawlita; William G Quint; Nubia Muñoz; Francesc X Bosch; Silvia de Sanjosé
Journal:  Int J Cancer       Date:  2014-05-30       Impact factor: 7.396

Review 4.  Mechanisms of persistence by small DNA tumor viruses.

Authors:  Nathan A Krump; Wei Liu; Jianxin You
Journal:  Curr Opin Virol       Date:  2018-10-01       Impact factor: 7.090

5.  HPV typing of high-grade dysplasia (CIN III) in cone biopsies of 38 HPV-vaccinated women.

Authors:  Ondrej Ondič; Jana Kašpírková; Ondřej Májek; Iva Kinkorová
Journal:  Virchows Arch       Date:  2013-11-26       Impact factor: 4.064

6.  From Human Papillomavirus (HPV) Detection to Cervical Cancer Prevention in Clinical Practice.

Authors:  Sin Hang Lee; Jessica S Vigliotti; Veronica S Vigliotti; William Jones
Journal:  Cancers (Basel)       Date:  2014-10-02       Impact factor: 6.639

7.  Human papillomavirus 16 is an aetiological factor of scrotal cancer.

Authors:  Núria Guimerà; Laia Alemany; Gordana Halec; Michael Pawlita; Gerard Vincent Wain; José Santos Salas Vailén; Jerome E Azike; David Jenkins; Silvia de Sanjosé; Wim Quint; F Xavier Bosch
Journal:  Br J Cancer       Date:  2017-04-04       Impact factor: 7.640

8.  Multivalent human papillomavirus l1 DNA vaccination utilizing electroporation.

Authors:  Kihyuck Kwak; Rosie Jiang; Subhashini Jagu; Joshua W Wang; Chenguang Wang; Neil D Christensen; Richard B S Roden
Journal:  PLoS One       Date:  2013-03-25       Impact factor: 3.240

9.  Prevalence and genetic variability in capsid L1 gene of rare human papillomaviruses (HPV) found in cervical lesions of women from North-East Brazil.

Authors:  Ana Pavla Almeida Diniz Gurgel; Bárbara Simas Chagas; Carolina Maria Medeiros do Amaral; Eugênia Maria Bezerra Albuquerque; Ivi Gonçalves Soares Santos Serra; Jacinto da Costa Silva Neto; Maria Tereza Cartaxo Muniz; Antonio Carlos de Freitas
Journal:  Biomed Res Int       Date:  2013-06-20       Impact factor: 3.411

10.  Oncogenic processes.

Authors:  Rita de Cassia Stocco; Franco Peppino Roperto; Lubna Nasir; Marcelo Palma Sircili
Journal:  Biomed Res Int       Date:  2014-01-16       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.